Tricida Inc (TCDA)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track Share on 𝕏

Stock chart
Ticker: TCDA Exchange: NSM


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale
Past 90 days
 
Value bought
 
Value sold
 
Net insiders buying
 
Trades (buy and sell)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Total value Details
2020-02-05 2020-02-03 PS Planned sale

KLAERNER GERRIT

President and CEO

Executive Director
2,900 -0.5%
36.58
106,082 USD 		2,900 -0.5% 36.58 106,082 USD
2020-02-05 2020-02-03 PS Planned sale

KLAERNER GERRIT

President and CEO

Executive Director
1,100 -0.2%
35.68
39,248 USD 		1,100 -0.2% 35.68 39,248 USD
2020-02-05 2020-02-03 PS Planned sale

HEJLEK EDWARD J

SVP, General Counsel & Secy.
7,869 -29.1%
36.63
288,241 USD 		7,869 -29.1% 36.63 288,241 USD
2020-02-05 2020-02-03 PS Planned sale

HEJLEK EDWARD J

SVP, General Counsel & Secy.
2,131 -10.0%
35.63
75,928 USD 		2,131 -10.0% 35.63 75,928 USD
2020-02-05 2020-02-03 PS Planned sale

Otto Dawn Parsell

Sr VP, Clinical Development
523 -67.2%
37.62
19,675 USD 		523 -67.2% 37.62 19,675 USD
2020-02-05 2020-02-03 PS Planned sale

Otto Dawn Parsell

Sr VP, Clinical Development
523 -67.2%
37.31
19,513 USD 		523 -67.2% 37.31 19,513 USD
2020-02-05 2020-02-03 PS Planned sale

Otto Dawn Parsell

Sr VP, Clinical Development
400 -61.1%
37.51
15,004 USD 		400 -61.1% 37.51 15,004 USD
2020-02-05 2020-02-03 PS Planned sale

Otto Dawn Parsell

Sr VP, Clinical Development
2,336 -78.1%
36.74
85,825 USD 		2,336 -78.1% 36.74 85,825 USD
2020-02-05 2020-02-03 PS Planned sale

Otto Dawn Parsell

Sr VP, Clinical Development
258 -7.9%
35.58
9,180 USD 		258 -7.9% 35.58 9,180 USD
2020-02-05 2020-02-03 PS Planned sale

Otto Dawn Parsell

Sr VP, Clinical Development
210 -45.2%
35.58
7,472 USD 		210 -45.2% 35.58 7,472 USD
2020-01-16 2020-01-15 PS Planned sale

KLAERNER GERRIT

President and CEO

Executive Director
4,000 -7.5%
35.26
141,040 USD 		4,000 -7.5% 35.26 141,040 USD
2020-01-06 2020-01-02 PS Planned sale

Otto Dawn Parsell

Sr VP, Clinical Development
2,365 -90.3%
37.20
87,978 USD 		2,365 -90.3% 37.20 87,978 USD
2020-01-06 2020-01-02 PS Planned sale

Otto Dawn Parsell

Sr VP, Clinical Development
1,885 -88.1%
36.84
69,443 USD 		1,885 -88.1% 36.84 69,443 USD
2020-01-06 2020-01-02 PS Planned sale

HEJLEK EDWARD J

SVP, General Counsel & Secy.
52 -0.3%
38.00
1,976 USD 		52 -0.3% 38.00 1,976 USD
2020-01-06 2020-01-02 PS Planned sale

HEJLEK EDWARD J

SVP, General Counsel & Secy.
9,948 -34.2%
37.01
368,175 USD 		9,948 -34.2% 37.01 368,175 USD
2020-01-03 2020-01-02 PS Planned sale

KLAERNER GERRIT

President and CEO

Executive Director
100 -0.0%
38.00
3,800 USD 		100 -0.0% 38.00 3,800 USD
2020-01-03 2020-01-02 PS Planned sale

KLAERNER GERRIT

President and CEO

Executive Director
3,900 -0.7%
37.13
144,807 USD 		3,900 -0.7% 37.13 144,807 USD
2019-12-26 2019-12-23 PS Planned sale

Stahl Wilhelm

Chief Tech Officer & Sr. VP

Officer
2,950 -16.6%
38.91
114,785 USD 		2,950 -16.6% 38.91 114,785 USD
2019-12-26 2019-12-23 PS Planned sale

Stahl Wilhelm

Chief Tech Officer & Sr. VP

Officer
50 -0.3%
38.90
1,945 USD 		50 -0.3% 38.90 1,945 USD
2019-12-23 2019-12-20 PS Planned sale

HEJLEK EDWARD J

SVP, General Counsel & Secy.

Officer
15,000 -50.2%
38.17
572,550 USD 		15,000 -50.2% 38.17 572,550 USD
2019-12-20 2019-12-18 PS Planned sale

KLAERNER GERRIT

President and CEO

Executive Director
103 -0.2%
39.66
4,085 USD 		103 -0.2% 39.66 4,085 USD
2019-12-20 2019-12-18 PS Planned sale

KLAERNER GERRIT

President and CEO

Executive Director
3,987 -6.9%
38.93
155,214 USD 		3,987 -6.9% 38.93 155,214 USD
2019-12-20 2019-12-18 PS Planned sale

KLAERNER GERRIT

President and CEO

Executive Director
18,440 -24.3%
38.91
717,500 USD 		18,440 -24.3% 38.91 717,500 USD
2019-12-20 2019-12-18 PS Planned sale

KLAERNER GERRIT

President and CEO

Executive Director
9,220 -10.8%
38.90
358,658 USD 		9,220 -10.8% 38.90 358,658 USD
2019-12-12 2019-12-11 S Sale

Bonita David P

Non-Executive Director Major owner
1,500,000 -13.5%
40.00
60,000,000 USD 		1,500,000 -13.5% 40.00 60,000,000 USD
2019-12-12 2019-12-11 S Sale

ORBIMED ADVISORS LLC

Non-Executive Director Major owner
1,500,000 -13.5%
40.00
60,000,000 USD 		1,500,000 -13.5% 40.00 60,000,000 USD
2019-12-12 2019-12-11 PS Planned sale

KLAERNER GERRIT

President and CEO

Executive Director
2,369 -0.4%
43.88
103,952 USD 		2,369 -0.4% 43.88 103,952 USD
2019-12-12 2019-12-11 PS Planned sale

KLAERNER GERRIT

President and CEO

Executive Director
5,203 -0.9%
43.32
225,394 USD 		5,203 -0.9% 43.32 225,394 USD
2019-12-12 2019-12-10 PS Planned sale

COUFAL SANDRA I

Non-Executive Director Major owner
713 -0.3%
43.28
30,859 USD 		713 -0.3% 43.28 30,859 USD
2019-12-12 2019-12-10 PS Planned sale

COUFAL SANDRA I

Non-Executive Director Major owner
1,620 -25.0%
43.17
69,935 USD 		1,620 -25.0% 43.17 69,935 USD
2019-12-11 2019-12-10 PS Planned sale

KLAERNER GERRIT

President and CEO

Executive Director
3,948 -0.7%
43.28
170,869 USD 		3,948 -0.7% 43.28 170,869 USD
2019-12-03 2019-12-02 PS Planned sale

KLAERNER GERRIT

President and CEO

Executive Director
4,000 -0.7%
39.49
157,960 USD 		4,000 -0.7% 39.49 157,960 USD
2019-12-03 2019-11-29 PS Planned sale

KLAERNER GERRIT

President and CEO

Executive Director
2,000 -2.3%
39.80
79,600 USD 		2,000 -2.3% 39.80 79,600 USD
2019-12-03 2019-11-29 PS Planned sale

KLAERNER GERRIT

President and CEO

Executive Director
2,000 -0.3%
39.80
79,600 USD 		2,000 -0.3% 39.80 79,600 USD
2019-11-27 2019-11-26 PS Planned sale

Otto Dawn Parsell

Sr VP, Clinical Development
1,884 -100.0%
39.60
74,606 USD 		1,884 -100.0% 39.60 74,606 USD
2019-11-27 2019-11-26 PS Planned sale

Otto Dawn Parsell

Sr VP, Clinical Development
739 -100.0%
39.59
29,257 USD 		739 -100.0% 39.59 29,257 USD
2019-11-27 2019-11-26 PS Planned sale

Otto Dawn Parsell

Sr VP, Clinical Development
1,616 -68.6%
39.60
63,994 USD 		1,616 -68.6% 39.60 63,994 USD
2019-11-27 2019-11-26 PS Planned sale

Otto Dawn Parsell

Sr VP, Clinical Development
1,507 -100.0%
39.61
59,692 USD 		1,507 -100.0% 39.61 59,692 USD
2019-11-27 2019-11-26 PS Planned sale

Alpern Robert J

1,000 -0.7%
39.59
39,590 USD 		1,000 -0.7% 39.59 39,590 USD
2019-11-26 2019-11-22 S Sale

Isern Brian M.

possible member of 10% group

Major owner
132,834 -4.6%
41.17
5,468,776 USD 		132,834 -4.6% 41.17 5,468,776 USD
2019-11-26 2019-11-22 S Sale

Isern Brian M.

possible member of 10% group

Major owner
48,030 -1.6%
40.53
1,946,656 USD 		48,030 -1.6% 40.53 1,946,656 USD
2019-11-26 2019-11-22 S Sale

COUFAL SANDRA I

Non-Executive Director Major owner
132,834 -4.6%
41.17
5,468,776 USD 		132,834 -4.6% 41.17 5,468,776 USD
2019-11-26 2019-11-22 S Sale

COUFAL SANDRA I

Non-Executive Director Major owner
48,030 -1.6%
40.53
1,946,656 USD 		48,030 -1.6% 40.53 1,946,656 USD
2019-11-22 2019-11-21 S Sale

COUFAL SANDRA I

Non-Executive Director Major owner
117,940 -3.8%
41.01
4,836,719 USD 		117,940 -3.8% 41.01 4,836,719 USD
2019-11-22 2019-11-21 S Sale

COUFAL SANDRA I

Non-Executive Director Major owner
13,648 -0.4%
40.31
550,151 USD 		13,648 -0.4% 40.31 550,151 USD
2019-11-22 2019-11-21 S Sale

COUFAL SANDRA I

Non-Executive Director Major owner
59,094 -7.1%
41.09
2,428,172 USD 		59,094 -7.1% 41.09 2,428,172 USD
2019-11-22 2019-11-21 S Sale

Isern Brian M.

possible member of 10% group

Major owner
117,940 -3.8%
41.01
4,836,719 USD 		117,940 -3.8% 41.01 4,836,719 USD
2019-11-22 2019-11-21 S Sale

Isern Brian M.

possible member of 10% group

Major owner
13,648 -0.4%
40.31
550,151 USD 		13,648 -0.4% 40.31 550,151 USD
2019-11-22 2019-11-21 S Sale

Isern Brian M.

possible member of 10% group

Major owner
59,094 -7.1%
41.09
2,428,172 USD 		59,094 -7.1% 41.09 2,428,172 USD
2019-11-22 2019-11-20 S Sale

COUFAL SANDRA I

Non-Executive Director Major owner
33,576 -1.1%
40.19
1,349,419 USD 		33,576 -1.1% 40.19 1,349,419 USD
2019-11-22 2019-11-20 S Sale

COUFAL SANDRA I

Non-Executive Director Major owner
20,222 -0.6%
39.55
799,780 USD 		20,222 -0.6% 39.55 799,780 USD
2019-11-22 2019-11-20 S Sale

COUFAL SANDRA I

Non-Executive Director Major owner
37,614 -4.3%
40.27
1,514,716 USD 		37,614 -4.3% 40.27 1,514,716 USD
2019-11-22 2019-11-20 S Sale

COUFAL SANDRA I

Non-Executive Director Major owner
19,173 -2.1%
39.54
758,100 USD 		19,173 -2.1% 39.54 758,100 USD
2019-11-22 2019-11-20 PS Planned sale

COUFAL SANDRA I

Non-Executive Director Major owner
713 -0.3%
40.21
28,670 USD 		713 -0.3% 40.21 28,670 USD
2019-11-22 2019-11-20 PS Planned sale

COUFAL SANDRA I

Non-Executive Director Major owner
1,520 -19.0%
40.24
61,165 USD 		1,520 -19.0% 40.24 61,165 USD
2019-11-22 2019-11-20 S Sale

Isern Brian M.

possible member of 10% group

Major owner
33,576 -1.1%
40.19
1,349,419 USD 		33,576 -1.1% 40.19 1,349,419 USD
2019-11-22 2019-11-20 S Sale

Isern Brian M.

possible member of 10% group

Major owner
20,222 -0.6%
39.55
799,780 USD 		20,222 -0.6% 39.55 799,780 USD
2019-11-22 2019-11-20 S Sale

Isern Brian M.

possible member of 10% group

Major owner
37,614 -4.3%
40.27
1,514,716 USD 		37,614 -4.3% 40.27 1,514,716 USD
2019-11-22 2019-11-20 S Sale

Isern Brian M.

possible member of 10% group

Major owner
19,173 -2.1%
39.54
758,100 USD 		19,173 -2.1% 39.54 758,100 USD
2019-11-21 2019-11-20 PS Planned sale

Stahl Wilhelm

Chief Tech Officer & Sr. VP

Officer
814 -5.2%
40.81
33,219 USD 		814 -5.2% 40.81 33,219 USD
2019-11-21 2019-11-20 PS Planned sale

Alpern Robert J

Non-Executive Director
2,439 -1.7%
40.65
99,145 USD 		2,439 -1.7% 40.65 99,145 USD
2019-11-19 2019-11-19 B Purchase

Parker Geoffrey M.

Chief Fin. Officer and Sr. VP

Officer
945 +1.9%
34.72
32,810 USD 		945 +1.9% 34.72 32,810 USD
2019-11-19 2019-11-18 B Purchase

Parker Geoffrey M.

Chief Fin. Officer and Sr. VP

Officer
19,055 +63.5%
34.28
653,205 USD 		19,055 +63.5% 34.28 653,205 USD
2019-11-14 2019-11-12 PS Planned sale

Alpern Robert J

1,159 -0.8%
39.92
46,267 USD 		1,159 -0.8% 39.92 46,267 USD
2019-11-14 2019-11-12 PS Planned sale

Stahl Wilhelm

Chief Tech Officer & Sr. VP
836 -5.3%
39.97
33,415 USD 		836 -5.3% 39.97 33,415 USD
2019-11-12 2019-11-07 PS Planned sale

Alpern Robert J

Non-Executive Director
3,953 -2.7%
39.93
157,843 USD 		3,953 -2.7% 39.93 157,843 USD
2019-11-12 2019-11-07 PS Planned sale

COUFAL SANDRA I

Non-Executive Director Major owner
100 -1.2%
40.02
4,002 USD 		100 -1.2% 40.02 4,002 USD
2019-11-07 2019-11-06 PS Planned sale

Stahl Wilhelm

Chief Tech Officer & Sr. VP
48 -0.3%
39.97
1,919 USD 		48 -0.3% 39.97 1,919 USD
2019-11-07 2019-11-06 PS Planned sale

Alpern Robert J

227 -0.2%
39.75
9,023 USD 		227 -0.2% 39.75 9,023 USD
2019-11-07 2019-11-05 PS Planned sale

Stahl Wilhelm

Chief Tech Officer & Sr. VP
991 -6.3%
40.02
39,660 USD 		991 -6.3% 40.02 39,660 USD
2019-11-07 2019-11-05 PS Planned sale

Alpern Robert J

1,605 -1.1%
39.89
64,023 USD 		1,605 -1.1% 39.89 64,023 USD
2019-11-06 2019-11-04 PS Planned sale

Stahl Wilhelm

Chief Tech Officer & Sr. VP

Officer
651 -4.2%
40.00
26,040 USD 		651 -4.2% 40.00 26,040 USD
2019-11-06 2019-11-04 PS Planned sale

Stahl Wilhelm

Chief Tech Officer & Sr. VP

Officer
2,000 -11.5%
39.56
79,120 USD 		2,000 -11.5% 39.56 79,120 USD
2019-11-06 2019-11-04 PS Planned sale

Alpern Robert J

Non-Executive Director
2,617 -1.7%
39.84
104,261 USD 		2,617 -1.7% 39.84 104,261 USD
2019-11-05 2019-11-01 PS Planned sale

VEITINGER KLAUS R DR

1,750 -3.3%
38.87
68,023 USD 		1,750 -3.3% 38.87 68,023 USD